Clinical Trials Logo
  1. Home
  2. Trismus
  3. NCT05615181
  4. Details
NCT05615181 Clinical Trial

Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)

Trismus Clinical Trial

— TRISMUS  

Official title:
Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05615181
Other study ID # 00009
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 22, 2020
Est. completion date December 31, 2022

Study information
Verified date August 2023
Source Centre Hospitalier de Valence
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).

Description:

Trismus is defined as a limitation in the mouth/jaw-opening ability due to a reduced mandible mobility. Trismus can occur from benign jaw related conditions, often referred to as temporomandibular disorders (TMD). It can also result from local or metastatic tumor growth of head and neck (H&N) tumors, and more importantly, as a debilitating side-effect to H&N oncology treatment, especially radiotherapy The Gothenburg Trismus Questionnaire (GTQ) is a Patient Reported Outcome, validated in English, portuguese and sweden language. The aim of this study is to develop a new tool in french language and to evaluate the specific impact of trismus on quality of life .

Recruitment information / eligibility
Status Completed
Enrollment 310
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Inclusion Criteria: - Patient treated for trismus - Age = 18 years old - Read, write and understand the French language - Exclusion Criteria: - Patient under guardianship, deprived of liberty, safeguard of justice - Refusal to participate in research

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Ch Valence Valence Drome

Sponsors (2)
Lead Sponsor Collaborator
Centre Hospitalier de Valence Göteborg University

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Gothenburg Trismus Questionnaire (GTQ) patient Reported Outcome measure: score 0-4 (0 means a better outcome, 4 means a worse outcome.) once at inclusion
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05671861 - Evaluating a Low-Cost Therapeutic Device in Managing Head and Neck Cancer Patients With Radiation-Related Trismus N/A
Recruiting NCT03442166 - Effectiveness of Light-emitting Diode (LED) Photobiomodulation in the Extraction of Retained Lower Third Molars Phase 2
Completed NCT03178110 - Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer N/A
Recruiting NCT03979924 - Mouth Opening, Prevention, Education, Nutrition (OPEN) N/A
Completed NCT03672669 - Comparison of the Effect of A-PRF and L-PRF on Outcomes After Removal of Impacted Mandibular Third Molar N/A
Active, not recruiting NCT00793052 - Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery N/A
Active, not recruiting NCT03170713 - Impact of Preemptive Intravenous Ibuprofen on Postoperative Edema and Trismus in the Third Molar Teeth N/A
Completed NCT04280809 - Effects of Low-level Laser Therapy After Surgical Removal of Impacted Lower Third Molar N/A
Completed NCT03480035 - Ideal Point of Transluminal Light in Tracheal Intubation With a Light Wand
Recruiting NCT02602431 - Low Laser Light Therapy After Impacted Third Molar Removal N/A
Completed NCT03492814 - Comparing Different Suturing Techniques on the Post-operative Morbidity After Removal of Impacted Mandibular Third Molar N/A
Not yet recruiting NCT06148077 - Manual Therapy for Oral Health on Head and Neck Cancer Survivors N/A
Not yet recruiting NCT02493179 - Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery Phase 4
Completed NCT02094690 - Physiotherapy for Radiation-induced Trismus N/A
Active, not recruiting NCT04005521 - Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer N/A
Not yet recruiting NCT04082793 - Photobiomodulation and Sonophoresis Improving Jaw Mobility and Quality of Life Among Head and Neck Cancer Survivors N/A
Suspended NCT00507208 - Dynasplint Therapy for Trismus in Head and Neck Cancer N/A
Completed NCT05679453 - Lornoxicam Versus Etodolac After Third Molar Surgery Phase 4
Completed NCT03690167 - Investigation of the Effects of CGF and A-PRF on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery N/A
Not yet recruiting NCT05176158 - Dexketoprofen Dosage According to Chronotherapy N/A